文献速递临床试验与 GCP

自然周期与程序化周期冻融胚胎移植:一项研究者发起的多中心随机对照试验方案

Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trial.
PubMed 文献 · Trials · 2021-09-27

NatPro 试验将 788 名女性随机分配至改良自然周期或程序化周期冻融胚胎移植,随访至多三个 FET 周期,主要比较活产妊娠者中子痫前期的比例,次要比较活产比例及伴严重特征子痫前期比例。

要点

  • 程序化 FET 缺乏黄体,可能增加子痫前期风险,需随机对照验证。
  • 主要结局为活产妊娠者中子痫前期的比例,随访至多三个 FET 周期。
  • 试验结果将为临床选择 FET 方案提供母体风险和活产率的依据。

核心结论

  • NatPro 试验旨在比较改良自然周期与程序化周期 FET 后子痫前期比例,并为活产率提供准确估计。

研究设计与样本

  • 研究者发起的双臂平行组多中心随机对照试验,计划随机化 788 名女性,随访至多三个 FET 周期。

主要发现

  • 原文未报告试验结果,仅描述研究方案与结局指标。

关键数值与推荐

  • 主要结局为活产妊娠女性中子痫前期的比例,比较改良自然周期(有黄体)与程序化周期(无黄体)两组。
  • 次要结局比较两组活产比例及伴严重特征子痫前期比例。

临床怎么用

  • 试验结果预期为临床选择 FET 方案时评估母体子痫前期风险和活产可能性提供指导。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized trials of assisted reproductive technology (ART) have been designed for outcomes of clinical pregnancy or live birth and have not been powered for obstetric outcomes such as preeclampsia, critical for maternal and fetal health. ART increasingly involves frozen embryo transfer (FET). Although there are advantages of FET, multiple studies have shown that risk of preeclampsia is increased with FET compared with fresh embryo transfer, and the reason for this difference is not clear. NatPro will compare the proportion of preeclampsia between two commonly used protocols for FET,modified natural and programmed cycle. METHODS: In this two-arm, parallel-group, multi-center randomized trial, NatPro will randomize 788 women to either modified natural or programmed FET and follow them for up to three FET cycles. Primary outcome will be the proportion of preeclampsia in women with a viable pregnancy assigned to a modified natural cycle FET (corpus luteum present) protocol compared to the proportion of preeclampsia in pregnant women assigned to a programmed FET (corpus luteum absent) protocol. Secondary outcomes will compare the proportion of live births and the proportion of preeclampsia with severe features between the protocols. CONCLUSION: This study has a potential significant impact on millions of women who pursue ART to build their families. NatPro is designed to provide clinically relevant guidance to inform patients and clinicians regarding maternal risk with programmed and modified natural cycle FET protocols. This study will also provide accurate point estimates regarding the likelihood of live birth with programmed and modified natural cycle FET. TRIAL REGISTRATION: ClinicalTrials.gov NCT04551807 . Registered on September 16, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Baksh S, Casper A, Christianson MS, et al. Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trial. Trials. 2021. PMID: 34579768. doi:10.1186/s13063-021-05637-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。